BBP vs. VRAI

Last updated Jun 5, 2026

BBP (Virtus LifeSci Biotech Products ETF) and VRAI (Virtus Real Asset Income ETF) are both exchange-traded funds - BBP is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Products Index, while VRAI is a REIT fund tracking the Indxx Real Asset Income Index. Both are passively managed. Over the past 5 years, BBP returned 10.90%/yr vs 5.64%/yr for VRAI. At a 0.41 correlation, their price movements are largely independent. BBP charges 0.79%/yr vs 0.55%/yr for VRAI.

Performance

BBP vs. VRAI - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Virtus LifeSci Biotech Products ETF (BBP) and Virtus Real Asset Income ETF (VRAI). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BBP achieves a 8.38% return, which is significantly lower than VRAI's 22.49% return.

BBP

• 1D: 2.44%
• 1M: -0.92%
• YTD: 8.38%
• 6M: 9.14%
• 1Y: 48.00%
• 3Y*: 17.11%
• 5Y*: 10.90%
• 10Y*: 11.72%

VRAI

• 1D: 1.14%
• 1M: 0.11%
• YTD: 22.49%
• 6M: 19.28%
• 1Y: 29.47%
• 3Y*: 12.52%
• 5Y*: 5.64%
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

BBP vs. VRAI - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
BBP Virtus LifeSci Biotech Products ETF	8.38%	33.15%	3.32%	17.88%	0.85%	-8.17%	22.24%	7.68%
VRAI Virtus Real Asset Income ETF	22.49%	6.67%	2.66%	6.12%	-9.96%	24.35%	-5.94%	5.61%

Correlation

The correlation between BBP and VRAI is 0.17, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.17
Correlation (3Y) Calculated over the trailing 3-year period	0.35
Correlation (5Y) Calculated over the trailing 5-year period	0.38
Correlation (All Time) Calculated using the full available price history since Feb 11, 2019	0.41

Over the past year, the correlation between BBP and VRAI has dropped to 0.17 - well below their long-term average of 0.41, suggesting their price drivers have been diverging.

BBP vs. VRAI - Sectors Allocation Comparison

Sectors	BBP	VRAI
Healthcare	100.0%	-
Basic Materials	-	7.7%
Communication Services	-	2.7%
Consumer Cyclical	-	-
Consumer Defensive	-	1.9%
Energy	-	32.4%
Financial Services	-	-
Industrials	-	-
Real Estate	-	33.6%
Technology	-	1.3%
Utilities	-	18.0%

Return for Risk

BBP vs. VRAI — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBP

BBP Risk / Return Rank: 70
BBP Sharpe Ratio Rank: 61
BBP Sortino Ratio Rank: 62
BBP Omega Ratio Rank: 55
BBP Calmar Ratio Rank: 89
BBP Martin Ratio Rank: 82

VRAI

VRAI Risk / Return Rank: 83
VRAI Sharpe Ratio Rank: 79
VRAI Sortino Ratio Rank: 81
VRAI Omega Ratio Rank: 75
VRAI Calmar Ratio Rank: 92
VRAI Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BBP vs. VRAI - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Products ETF (BBP) and Virtus Real Asset Income ETF (VRAI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	BBP	VRAI	Difference
Sharpe ratio: Return per unit of total volatility	2.02	2.50	-0.48
Sortino ratio: Return per unit of downside risk	2.87	3.54	-0.67
Omega ratio: Gain probability vs. loss probability	1.33	1.44	-0.10
Calmar ratio: Return relative to maximum drawdown	5.20	6.14	-0.95
Martin ratio: Return relative to average drawdown	16.27	19.39	-3.12
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

BBP vs. VRAI - Sharpe Ratio Comparison

The current BBP Sharpe Ratio is 2.02, which is comparable to the VRAI Sharpe Ratio of 2.50. The chart below compares the historical Sharpe Ratios of BBP and VRAI, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	BBP	VRAI	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.02	2.50	-0.48
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.42	0.34	+0.08
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.43	—	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.40	0.29	+0.11

Drawdowns

BBP vs. VRAI - Drawdown Comparison

The maximum BBP drawdown since its inception was -44.32%, smaller than the maximum VRAI drawdown of -47.51%. Use the drawdown chart below to compare losses from any high point for BBP and VRAI.

Drawdown Indicators

	BBP	VRAI	Difference
Max Drawdown Largest peak-to-trough decline	-44.32%	-47.51%	+3.19%
Max Drawdown (1Y) Largest decline over 1 year	-9.28%	-4.82%	-4.46%
Max Drawdown (3Y) Largest decline over 3 years	-26.09%	-16.89%	-9.20%
Max Drawdown (5Y) Largest decline over 5 years	-38.28%	-26.71%	-11.57%
Max Drawdown (10Y) Largest decline over 10 years	-44.32%	—	—
Current Drawdown Current decline from peak	-4.18%	0.00%	-4.18%
Average Drawdown Average peak-to-trough decline	-12.02%	-10.09%	-1.93%
Ulcer Index Depth and duration of drawdowns from previous peaks	2.96%	1.52%	+1.44%

Volatility

BBP vs. VRAI - Volatility Comparison

Virtus LifeSci Biotech Products ETF (BBP) has a higher volatility of 8.03% compared to Virtus Real Asset Income ETF (VRAI) at 3.63%. This indicates that BBP's price experiences larger fluctuations and is considered to be riskier than VRAI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BBP	VRAI	Difference
Volatility (1M) Calculated over the trailing 1-month period	8.03%	3.63%	+4.40%
Volatility (6M) Calculated over the trailing 6-month period	18.52%	8.47%	+10.05%
Volatility (1Y) Calculated over the trailing 1-year period	23.84%	11.88%	+11.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.37%	16.65%	+9.72%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	27.41%	22.13%	+5.28%

BBP vs. VRAI - Expense Ratio Comparison

BBP has a 0.79% expense ratio, which is higher than VRAI's 0.55% expense ratio.

Dividends

BBP vs. VRAI - Dividend Comparison

BBP has not paid dividends to shareholders, while VRAI's dividend yield for the trailing twelve months is around 3.19%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
BBP Virtus LifeSci Biotech Products ETF	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.18%	0.00%	1.29%
VRAI Virtus Real Asset Income ETF	3.19%	4.68%	7.13%	5.02%	4.48%	3.34%	3.91%	2.80%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions

Can I hold both BBP and VRAI in my portfolio?

BBP and VRAI have a correlation of 0.17, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BBP or VRAI?

BBP has higher volatility (8.03%) compared to VRAI (3.63%). In terms of maximum drawdown, BBP dropped -44.32% vs VRAI's -47.51%.

Which ETF is better, BBP or VRAI?

On 5-year performance, BBP leads with 10.90% vs 5.64% for VRAI. On fees, VRAI is cheaper at 0.55% per year. On volatility, VRAI has been the lower-risk option at 3.63%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, BBP or VRAI?

Over the 5-year period, BBP has performed better with a 10.90% return vs 5.64%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, BBP or VRAI?

VRAI is cheaper with a 0.55% expense ratio, compared with 0.79% for BBP.

Which ETF pays a higher dividend yield, BBP or VRAI?

VRAI has the higher dividend yield at 3.19%, compared with 0.00% for BBP.

What is the main difference between BBP and VRAI?

BBP is categorized as Health & Biotech Equities, while VRAI is REIT. BBP tracks LifeSci Biotechnology Products Index, while VRAI tracks Indxx Real Asset Income Index. Their fees differ too: 0.79% for BBP and 0.55% for VRAI.

Which has better risk-adjusted returns?

VRAI currently has the higher Sharpe Ratio (2.50 vs 2.02), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.